Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

AgelessRx vs Velvet Rx

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.1

AgelessRx

Best for longevity-focused GLP-1 care (pending verification)
★★★3.6

Starting at $199/mo

CompoundedBrandSemaglutideTirzepatide
Visit AgelessRx
6.6

Velvet Rx

Best for cash-pay patients comfortable with a compounded-GLP-1 telehealth model who prioritize three publicly-listed SKUs and bundled shipping over LegitScript / NABP certification, named pharmacy partner, or per-state availability verification
★★★☆☆3.3

Starting at $139/mo

CompoundedSemaglutideTirzepatideOral GLP-1
Visit Velvet Rx

Side-by-Side Comparison

FeatureAgelessRxVelvet Rx
Overall Score7.1/106.6/10
Starting Price$199/mo$139/mo
Editorial Rating3.6 ★ /53.3 ★ /5
Features6 features8 features
States Available00
Compounded✓ Yes✓ Yes
Brand Name✓ Yes
FSA/HSA Accepted✓ Yes
FDA WarningsNoneNone

Pros & Cons

AgelessRx

Pros

  • Established brand based in Ann Arbor, MI with US-licensed providers
  • Offers both compounded and brand-name (Wegovy) options
  • Longevity-first positioning — patients get a broader metabolic health framing vs single-condition GLP-1 funnels
  • Listed in both competitor directories

Cons

  • Stub entry — pricing, states served, and GLP-1-specific intake workflow need YMYL verification
  • Confidence LOW until verified
  • Longevity-first positioning means GLP-1 is one of several products — patients looking specifically for GLP-1 care may be funneled into a broader longevity intake

Velvet Rx

Pros

  • Publicly-disclosed pricing across 3 SKUs (semaglutide injection $299, tirzepatide injection $359, Oral GLP-1 $349) — uncommon transparency in the compounded telehealth segment
  • First-month promo pricing displayed verbatim on home: $139 sema / $199 tirz / $189 oral
  • Doctor consult, prescription, 4 weeks of medication, AND free 1-2 day shipping all included in single monthly price (verbatim: 'Same price, every dose. No hidden fees')
  • FSA / HSA eligibility claimed verbatim on the home
  • Three modalities under one roof: injectable sema, injectable tirz, and an oral GLP-1 option
  • No insurance accepted — fully cash-pay model with no membership fee disclosed

Cons

  • Oral GLP-1 SKU does NOT name the specific drug (Rybelsus? Foundayo? compounded oral semaglutide? — not disclosed) — material transparency gap given the three are clinically distinct (Rybelsus is T2D-indicated only, Foundayo is FDA-approved for chronic weight management, compounded oral has unsettled regulatory status)
  • No LegitScript Certified or NABP .pharmacy seal displayed on home or footer
  • No legal entity name disclosed publicly (footer reads only 'Copyright © 2025 VelvetRx')
  • No physical address disclosed publicly
  • No partner pharmacy named — does NOT disclose which 503A or 503B compounding pharmacy fills prescriptions
  • States available NOT enumerated — no state-by-state availability disclosure
  • Pricing display has internal inconsistency: hero shows '$299 $139 today' for sema; pricing card adds 'Save $60 instantly on your first month, then $100 off each month' which would imply $239 first / $199 ongoing — different math than the headline $139
  • Marketing claims include unverifiable percentages ('92% of patients are on track by month one,' '15% average body weight loss in first 90 days,' '9/10 patients say it's the most effective treatment they've ever tried') with no cited methodology, sample size, or independent audit
  • No FDA warning letters found for 'Velvet Rx' or 'VelvetRx' in the FDA warning-letter database as of 2026-05-10 — but this absence is not affirmative evidence of pharmacy quality

Our Verdict

Winner: AgelessRxScore: 7.1/10

AgelessRx edges out Velvet Rx with a higher overall score of 7.1/10 and is particularly strong for longevity-focused GLP-1 care (pending verification). Velvet Rx remains a solid alternative, especially if you're looking for cash-pay patients comfortable with a compounded-GLP-1 telehealth model who prioritize three publicly-listed SKUs and bundled shipping over LegitScript / NABP certification, named pharmacy partner, or per-state availability verification.

Glossary references

Key terms in this article, linked to their canonical definitions.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.